Skip to content

13F-HR filed by Soleus Capital Management, L.P.

Soleus Capital Management, L.P. filed this 13F-HR for the quarter ended 2019-12-31, filed 2020-02-14, with 49 holding rows worth $103,701,000.

Accession
0001802630-20-000002
Filed
2020-02-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2019

A holdings report, 49 entries on the cover page, a total value of $103,701,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $103,678,000 with VALUE read as thousands by filing date, 13F file number 028-20043. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
GRIFOLS S A398438408SP ADR REP B NVT452,900$10,548,000thousands by filing date
ESSA PHARMA INC29668H708COM NEW1,634,369$8,989,000thousands by filing date
WRIGHT MED GROUP N VN96617118ORD SHS226,700$6,909,000thousands by filing date
IVERIC BIO INC46583P102COM668,371$5,734,000thousands by filing date
ALLERGAN PLCG0177J108SHS28,500$5,448,000thousands by filing date
Adverum Biotechnologies, Inc.00773U108Common Stock342,800$3,949,000thousands by filing date
DEXCOM INC COM252131107Stock17,600$3,849,000thousands by filing date
AEGLEA BIOTHERAPEUTICS INC00773J103COM458,165$3,500,000thousands by filing date
ALEXION PHARMACEUTICALS INC015351109COM31,300$3,385,000thousands by filing date
Misonix Inc604871103COM178,596$3,323,000thousands by filing date
IRADIMED CORP46266A109COMMON STOCK140,752$3,290,000thousands by filing date
VERICEL CORP92346J108COM183,680$3,196,000thousands by filing date
EIGER BIOPHARMACEUTICALS INC28249U105COM205,407$3,060,000thousands by filing date
ESTABLISHMENT LABS HOLDINGSG31249108COMMON STOCK93,560$2,587,000thousands by filing date
DERMIRA INC24983L104COM164,600$2,495,000thousands by filing date
AXOGEN INC05463X106COM127,450$2,280,000thousands by filing date
BIOGEN INC COM09062X103Stock7,500$2,225,000thousands by filing date
HUMANA INC COM444859102Stock5,800$2,125,000thousands by filing date
XENON PHARMACEUTICALS INC COM98420N105Stock161,600$2,118,000thousands by filing date
BLUEPRINT MEDICINES CORP09627Y109COM26,400$2,114,000thousands by filing date
CONSTELLATION PHARMACEUTICALS INC.210373106Common Stock42,100$1,983,000thousands by filing date
AMICUS THERAPEUTICS INC03152W109COM188,800$1,838,000thousands by filing date
HARPOON THERAPEUTICS INC41358P106COM123,200$1,822,000thousands by filing date
KADMON HLDGS INC48283N106COM350,300$1,586,000thousands by filing date
CRISPR THERAPEUTICS AG NAMEN AKTH17182108Stock22,300$1,358,000thousands by filing date
STERIS PLC SHS USDG8473T100Stock8,800$1,341,000thousands by filing date
STAAR SURGICAL CO COM PAR $0.01852312305Stock35,940$1,264,000thousands by filing date
ZYMEWORKS INC98985W102COM22,700$1,031,000thousands by filing date
NEVRO CORP64157F103COM8,246$969,000thousands by filing date
ZEALAND PHARMA A/S98920Y304CMN26,882$892,000thousands by filing date
ZAFGEN INC98885E103COM803,963$892,000thousands by filing date
ICAD INC44934S206COM NEW94,900$737,000thousands by filing date
FLEXION THERAPEUTICS INC33938J106COM34,900$722,000thousands by filing date
Rafael Holdings Inc Class B75062E106COM37,925$676,000thousands by filing date
INSPIRE MED SYS INC COM457730109Stock9,008$668,000thousands by filing date
ARENA PHARMACEUTICALS INC040047607COM NEW11,100$504,000thousands by filing date
TANDEM DIABETES CARE INC875372203COM NEW7,600$453,000thousands by filing date
NATERA INC COM632307104Stock13,000$437,000thousands by filing date
LIVONGO HEALTH INC539183103COM16,866$422,000thousands by filing date
ESPERION THERAPEUTICS INC NEW COM29664W105Stock6,700$399,000thousands by filing date
GUARDANT HEALTH INC COM40131M109Stock4,900$382,000thousands by filing date
REVANCE THERAPEUTICS INC761330109COM23,200$376,000thousands by filing date
ARVINAS INC04335A105COM8,700$357,000thousands by filing date
PTC THERAPEUTICS INC69366J200COM6,800$326,000thousands by filing date
ARGENX SE SPONSORED ADR04016X101ADR1,500$240,000thousands by filing date
SHOCKWAVE MED INC82489T104COM5,400$237,000thousands by filing date
DICERNA PHARMACEUTICALS INC253031108COM10,700$235,000thousands by filing date
FATE THERAPEUTICS INC31189P102COM11,400$223,000thousands by filing date
SYNDAX PHARMACEUTICALS INC87164F105COM20,980$184,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001802630-20-000002this filing2020-02-14acceptance time not in the bulk data set